NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 27 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,736,600 | -50.9% | 1,900,000 | -50.0% | 0.00% | – |
Q1 2023 | $3,534,000 | +105.0% | 3,800,000 | +100.0% | 0.00% | – |
Q4 2022 | $1,724,250 | -3.1% | 1,900,000 | 0.0% | 0.00% | – |
Q3 2022 | $1,779,000 | +1.5% | 1,900,000 | 0.0% | 0.00% | – |
Q2 2022 | $1,752,000 | -13.9% | 1,900,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,035,000 | -2.9% | 1,900,000 | 0.0% | 0.00% | – |
Q4 2021 | $2,096,000 | -18.0% | 1,900,000 | 0.0% | 0.00% | – |
Q3 2021 | $2,557,000 | -22.1% | 1,900,000 | 0.0% | 0.00% | – |
Q2 2021 | $3,282,000 | +12.4% | 1,900,000 | 0.0% | 0.00% | – |
Q1 2021 | $2,920,000 | -44.5% | 1,900,000 | -34.5% | 0.00% | – |
Q4 2020 | $5,258,000 | +18.1% | 2,900,000 | 0.0% | 0.00% | – |
Q3 2020 | $4,453,000 | +13.2% | 2,900,000 | 0.0% | 0.00% | – |
Q2 2020 | $3,934,000 | – | 2,900,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 42,000,000 | $39,609,000 | 0.79% |
WOLVERINE ASSET MANAGEMENT LLC | 47,866,000 | $45,100,000 | 0.49% |
Context Capital Management, LLC | 7,689 | $7,201,000 | 0.48% |
PFM Health Sciences, LP | 9,000,000 | $8,519,000 | 0.31% |
PALISADE CAPITAL MANAGEMENT, LP | 1,534,000 | $1,446,000 | 0.04% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,667,000 | $5,364,000 | 0.03% |
Rock Springs Capital Management LP | 500,000 | $473,000 | 0.01% |
BNP PARIBAS FINANCIAL MARKETS | 28,872 | $1,345,435,000 | 0.00% |
LAZARD ASSET MANAGEMENT LLC | 0 | $946,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 701,000 | $659,124,000 | 0.00% |